InnovAge Holding Corp. (NASDAQ: INNV)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001834376
Market Cap 914.99 Mn
P/B 3.56
P/E 141.33
P/S 1.00
ROIC (Qtr) 2.51
Div Yield % 0.00
Rev 1y % (Qtr) 14.69
Total Debt (Qtr) 95.36 Mn
Debt/Equity (Qtr) 0.37
Add ratio to table...

About

InnovAge Holding Corp., or INNV, is a leading healthcare delivery platform operating within the healthcare industry. The company primarily focuses on providing comprehensive, capitated care to high-cost seniors, many of whom are dual-eligible. InnovAge's unique approach emphasizes improving the quality of care while reducing costs, making it an attractive option for government payors and individuals alike. InnovAge's main business activities revolve around its Program of All-Inclusive Care for the Elderly (PACE), which serves the frail elderly...

Read more

Investment thesis

Bull case

  • Strong operating cash flow of 58.91M provides robust 0.62x coverage of total debt 95.36M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 83.21M provide 6.76x coverage of short-term debt 12.32M, demonstrating strong liquidity position and minimal refinancing risk.
  • Operating cash flow of 58.91M provides exceptional 12.95x coverage of interest expenses 4.55M, showing strong debt service capability.
  • Strong tangible asset base of 381.89M provides 4x coverage of total debt 95.36M, indicating robust asset backing and low credit risk.
  • Robust free cash flow of 49.75M exceeds capital expenditure of 9.16M by 5.43x, indicating strong organic growth funding capability.

Bear case

  • Operating cash flow of 58.91M barely covers its investment activities of (10.88M), with a coverage ratio of -5.42, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 83.21M provide limited coverage of acquisition spending of (1.06M), which is -78.65x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • Operating earnings of 12.80M show weak coverage of depreciation charges of 18.74M, with a 0.68 ratio indicating high capital intensity and potential reinvestment needs.
  • Free cash flow of 49.75M represents just -6.10x of debt issuance (8.16M), suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • Tax assets of 3.31M provide limited offset against tax liabilities of 9.27M, which is 0.36x, indicating potential future cash flow pressure from tax obligations.

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 126.41 Bn 18.63 1.67 48.35 Bn
2 UHS Universal Health Services Inc 23.26 Bn 34.22 2.61 5.11 Bn
3 THC Tenet Healthcare Corp 21.11 Bn 15.01 0.99 13.17 Bn
4 FMS Fresenius Medical Care AG 14.42 Bn 17.06 0.62 14.98 Bn
5 EHC Encompass Health Corp 13.38 Bn 30.01 2.91 2.66 Bn
6 ENSG Ensign Group, Inc 12.18 Bn 35.41 2.41 2.21 Bn
7 DVA Davita Inc. 11.17 Bn 14.95 0.82 12.87 Bn
8 CHE Chemed Corp 8.11 Bn 81.70 5.57 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.79 1.24
EV to Cash from Ops. EV/CFO 16.06 15.08
EV to Debt EV to Debt 9.92 11.01
EV to EBIT EV/EBIT 73.89 15.96
EV to EBITDA EV/EBITDA 33.80 11.44
EV to Free Cash Flow [EV/FCF] EV/FCF 19.01 21.76
EV to Market Cap EV to Market Cap 1.03 619.57
EV to Revenue EV/Rev 1.03 2.71
Price to Book Value [P/B] P/B 3.56 -6.00
Price to Earnings [P/E] P/E 141.33 12.61
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.14
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.46
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 2.81 -94.29
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -25.48 -116.62
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 80.54 46.03
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.98
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 147.76 -42.57
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 499.39 91.55
EBIT Growth (1y) % EBIT 1y % (Qtr) 164.70 -56.79
EBT Growth (1y) % EBT 1y % (Qtr) 134.07 -111.80
EPS Growth (1y) % EPS 1y % (Qtr) 130.00 -19.28
FCF Growth (1y) % FCF 1y % (Qtr) 1,955.11 188.37
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 30.97 20.14
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.74 1.02
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.58 0.40
Current Ratio Curr Ratio (Qtr) 1.26 1.36
Debt to Equity Ratio Debt/Equity (Qtr) 0.37 -13.23
Interest Cover Ratio Int Coverage (Qtr) 2.81 -94.29
Times Interest Earned Times Interest Earned (Qtr) 2.81 -94.29
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 3.40 -75.46
EBIT Margin % EBIT Margin % (Qtr) 1.40 -74.60
EBT Margin % EBT Margin % (Qtr) 0.90 -85.12
Gross Margin % Gross Margin % (Qtr) 20.30 23.17
Net Profit Margin % Net Margin % (Qtr) 0.70 -85.79